March 26, 2008 07:00 ET

Pharma-Bio Industry Construction Injects $22 Billion Into North American Economy, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - March 26, 2008) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- A recent survey of active reported projects in Industrial Info's Pharmaceutical Tracker has revealed that 243 North American manufacturing plants and research facilities worth nearly $22 billion are currently under development. As discussed in detail in the New 2008 Pharmaceutical-Biotech Outlook, most of the manufacturing sites target the production of vaccines or biological therapies. One of the top projects, representing about $1 billion, is Bristol-Myers Squibb's (NYSE:BMY) (New York, New York) massive biologics manufacturing campus in Devens, Massachusetts.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=130110, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is a marketing information service specializing in industrial process and energy related industries with products and services ranging from industry news, forecasting, plant and project databases, as well as multimedia advertising campaign assistance. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.